Literature DB >> 3510162

Characterization of cerulenin-resistant mutants of Candida albicans.

K A Hoberg, R L Cihlar, R A Calderone.   

Abstract

Cerulenin, an inhibitor of fatty acid biosynthesis, has been used to study the role of the plasma membrane in germination of Candida albicans. To further elucidate this association, spontaneous, cerulenin-resistant mutants of C. albicans were isolated. Two of the mutants, 4918-2 and 4918-10, were compared biochemically with wild-type cells (4918). All strains grew equally well at 37 degrees C and synthesized fatty acids at comparable rates in the absence of the drug. In the presence of cerulenin, wild-type cells did not proceed through a logarithmic growth stage and exhibited a significantly impaired ability to incorporate [3H]acetate into newly synthesized lipid material. All strains were examined ultrastructurally. Alterations were observed in the membranous structures of cerulenin-treated wild-type cells. Such changes were not observed in cerulenin-treated mutant strains. Further examination of mutant strains revealed differences in cell wall protein and polysaccharide compositions when compared with those of wild-type cells. These apparent alterations in cell surface components may be correlated with the reduced abilities of mutant strains to adhere, in vitro, to mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510162      PMCID: PMC261071          DOI: 10.1128/iai.51.1.102-109.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Mannan-protein location and biosynthesis in plasma membranes from the yeast form of Candida albicans.

Authors:  M S Marriott
Journal:  J Gen Microbiol       Date:  1977-11

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 3.  The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis.

Authors:  S Omura
Journal:  Bacteriol Rev       Date:  1976-09

4.  The formation of glycosidic bonds in yeast glycoproteins. Intracellular localisation of the reactions.

Authors:  L Lehle; F Bauer; W Tanner
Journal:  Arch Microbiol       Date:  1977-07-26       Impact factor: 2.552

5.  Serological and cellular immune activity of peptidoglucomannan fractions of Candida albicans cell walls.

Authors:  E Reiss; S H Stone; H F Hasenclever
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

6.  Use of tannic acid as a fixative-mordant to improve the ultrastructural appearance of Candida albicans blastospores.

Authors:  M A Persi; J C Burnham
Journal:  Sabouraudia       Date:  1981-03

7.  Evidence for mannose-mediated adherence of Candida albicans to human buccal cells in vitro.

Authors:  R L Sandin; A L Rogers; R J Patterson; E S Beneke
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

8.  Adherence of Candida albicans and other Candida species to mucosal epithelial cells.

Authors:  R D King; J C Lee; A L Morris
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

9.  Strain variation and morphogenesis of yeast- and mycelial-phase Candida albicans in low-sulfate, synthetic medium.

Authors:  M Manning; T G Mitchell
Journal:  J Bacteriol       Date:  1980-05       Impact factor: 3.490

10.  Adherence of Candida albicans to a fibrin-platelet matrix formed in vitro.

Authors:  P A Maisch; R A Calderone
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

View more
  13 in total

Review 1.  Adherence and receptor relationships of Candida albicans.

Authors:  R A Calderone; P C Braun
Journal:  Microbiol Rev       Date:  1991-03

2.  Mannan composition of the hyphal form of two relatively avirulent mutants of Candida albicans.

Authors:  A Saxena; G E McElhaney-Feser; R L Cihlar
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

3.  Candida albicans C3d receptor, isolated by using a monoclonal antibody.

Authors:  L Linehan; E Wadsworth; R Calderone
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

4.  Identification of C3d receptors on Candida albicans.

Authors:  R A Calderone; L Linehan; E Wadsworth; A L Sandberg
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

5.  A monoclonal antibody that defines a surface antigen on Candida albicans hyphae cross-reacts with yeast cell protoplasts.

Authors:  M W Ollert; R A Calderone
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

Review 6.  Genetics of Candida albicans.

Authors:  S Scherer; P T Magee
Journal:  Microbiol Rev       Date:  1990-09

7.  Adherence of cell surface mutants of Candida albicans to buccal epithelial cells and analyses of the cell surface proteins of the mutants.

Authors:  M Fukayama; R A Calderone
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

8.  Characterization of epitopes recognized by Candida factor 1 and 9 antisera by use of Saccharomyces cerevisiae mnn mutants.

Authors:  H Ataoglu; J Zueco; R Sentandreu
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

9.  Isolation and preliminary characterization of the 14- to 18-kilodalton Candida albicans antigen as a phospholipomannan containing beta-1,2-linked oligomannosides.

Authors:  P A Trinel; M Borg-von-Zepelin; G Lepage; T Jouault; D Mackenzie; D Poulain
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Role of specific determinants in mannan of Candida albicans serotype A in adherence to human buccal epithelial cells.

Authors:  Y Miyakawa; T Kuribayashi; K Kagaya; M Suzuki; T Nakase; Y Fukazawa
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.